Drug Type Antibody |
Synonyms- |
Target |
Action inhibitors |
Mechanism SVEP1 inhibitors(sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Bone metastases | Preclinical | Israel | 30 Nov 2006 |






